| Literature DB >> 12714518 |
Christopher P Shelburne1, Margaret E McCoy, Roland Piekorz, Veronica Sexl, Kwan-Ho Roh, Sarah M Jacobs-Helber, Sheila R Gillespie, Daniel P Bailey, Paria Mirmonsef, Meredith N Mann, Mohit Kashyap, Harry V Wright, Hey Jin Chong, L Andrew Bouton, Brian Barnstein, Carlos D Ramirez, Kevin D Bunting, Steven Sawyer, Chris S Lantz, John J Ryan.
Abstract
Interleukin-3 (IL-3) and stem cell factor (SCF) are important mast cell growth and differentiation factors. Since both cytokines activate the transcription factor signal transducer and activator of transcription 5 (Stat5), a known regulator of proliferation and survival, we investigated the effects of Stat5 deficiency on mast cell development and survival. Bone marrow-derived mast cell (BMMC) populations cultured from Stat5A/B-deficient mice survived in IL-3 + SCF, but not in either cytokine alone. These cells demonstrated reduced expression of Bcl-2, Bcl-x(L), cyclin A2, and cyclin B1, with increased apoptosis and delayed cell cycle progression during IL-3 or SCF culture. Finally, the absence of Stat5 resulted in loss of in vivo mast cell development, as judged by assessments of Stat5-deficient mice and transplantation of Stat5-deficient bone marrow cells to mast cell-deficient recipient mice. These results indicate that Stat5A and Stat5B are critical regulators of in vitro and in vivo mast cell development and survival.Entities:
Mesh:
Substances:
Year: 2003 PMID: 12714518 DOI: 10.1182/blood-2002-11-3490
Source DB: PubMed Journal: Blood ISSN: 0006-4971 Impact factor: 22.113